Physician profile
John C Baumann
NPI 1619917507
$472.21
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $29.04 · 2021: $54.20 · 2022: $125 · 2024: $28.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $28.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $28.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Epizyme, INC. | $125.00 | 2022 | |
| Abbvie INC. | $41.35 | 2021-2024 | |
| Astrazeneca Pharmaceuticals Lp | $29.50 | 2019 | |
| Amgen INC. | $25.47 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.19 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.97 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $14.94 | 2020 | |
| Taiho Oncology, INC. | $14.71 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.56 | 2019 | |
| Seagen INC. | $14.52 | 2019 | |
| Genzyme Corporation | $14.48 | 2019 | |
| Glaxosmithkline, LLC. | $14.35 | 2021 | |
| Shire North American Group INC | $14.15 | 2019 | |
| Heron Therapeutics, INC. | $14.10 | 2020 | |
| Clovis Oncology, INC. | $13.99 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $13.87 | 2019 | |
| Emd Serono, INC. | $13.63 | 2021 | |
| Lilly USA, LLC | $13.49 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $13.15 | 2021 | |
| Dova Pharmaceuticals | $12.79 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.53 | 2019 | |
| Celgene Corporation | $11.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Baumann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.